AA
Abdulafeez Akinloye

Publications (2)

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
Article scientifique · 2022
Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
Article scientifique · 2021

Domaines principaux

Sciences de la santé2

Statistiques

Consultations6
Téléchargements0